期刊文献+

荧光原位杂交技术检测慢性淋巴细胞白血病细胞遗传学的异常 被引量:2

Detecting cytogenetic aberrations in chronic lymphocytic leukemia with fluorescence in situ hybridization
原文传递
导出
摘要 目的:探讨荧光原位杂交(FISH)技术检测慢性淋巴细胞白血病(CLL)患者染色体异常的临床价值。方法:运用FISH技术,采用5种特异性DNA探针检测46例CLL患者的染色体异常,并结合患者的临床资料,分析各种染色体异常在临床诊断及预后判断中的价值。结果:46例CLL患者中,32例出现染色体异常,总异常检出率为69.6%,其中del(11q22.3)8例(17.4%),del(13q14.3)14例(30.4%),P53缺失7例(15.2%),del(13q14)5例(10.9%),CSP12阳性10例(21.7%)。结论:FISH技术检测染色体异常的敏感性和特异性较高。del(13q14)是CLL患者最常见的染色体异常。存在基因异常的患者预后较正常者差,尤其是存在P53基因缺失的患者。 Objective:To investigate the clinical significance of the detection of chromosomal abnormalities in chronic lymphocytic leukemia(CLL)patients by fluorescence in situ hybridization(FISH)technology.Method:Using five kinds of specific DNA probes to detect the chromosomal abnormalities in 46CLL patients and combined with clinical data,we analyzed the value of each chromosomal abnormality in the clinical diagnosis and prognosis.Result:Thirty-two patients showed chromosomal abnormalities,with total abnormal rates 69.6%.The positive rates of del(11q22.3),del(13q14.3),P53deletion,del(13q14),trisomy 12were 17.4%,30.4%,15.2%,10.9%and 21.7%,respectively.Conclusion:The sensitivity and specificity of FISH technique for the detection of chromosomal abnormalities are both high.del(13q14)is the most common chromosome abnormality in CLL patients.The prognosis of patients with abnormal FISH results is significantly worse than that of normal ones.P53gene can affect the prognosis of CLL patients mostly.
出处 《临床血液学杂志》 CAS 2014年第A02期240-243,共4页 Journal of Clinical Hematology
基金 卫生部科研课题(No:WKJ 2007-3-001)
关键词 慢性淋巴细胞白血病 荧光原位杂交 细胞遗传学异常 chronic lymphocytic leukemia fluorescence in situ hybridization cytogenetic aberrations
  • 相关文献

参考文献13

  • 1张之南主编..血液病诊断及疗效标准 第2版[M].北京:科学出版社,1998:434.
  • 2Beyhan Durak,O. Meltem Akay,Vahap Aslan,Muhsin Ozdemir,Fezan Sahin,Sevilhan Artan,Zafer Gülbas.Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia[J].Cancer Genetics and Cytogenetics.2009(2) 被引量:1
  • 3Thorsten Zenz,Hartmut D?hner,Stephan Stilgenbauer.Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia[J].Best Practice & Research Clinical Haematology.2007(3) 被引量:1
  • 4Armand B. Glassman,Kimberly J. Hayes.The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia[J].Cancer Genetics and Cytogenetics.2005(1) 被引量:1
  • 5G. S.Nowakowski,G. W.Dewald,J. D.Hoyer,S. F.Paternoster,K. J.Stockero,S. R.Fink,S. A.Smoley,E. D.Remstein,R. L.Phyliky,T. G.Call,T. D.Shanafelt,N. E.Kay,C. S.Zent.Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia[J].British Journal of Haematology.2005(1) 被引量:1
  • 6Gordon W.Dewald,Stephanie R.Brockman,Sarah F.Paternoster,Nancy D.Bone,Judith R.O’Fallon,CristineAllmer,Charles D.James,Diane F.Jelinek,Renee C.Tschumper,Curtis A.Hanson,Rajiv K.Pruthi,Thomas E.Witzig,Timothy G.Call,Neil E.Kay.Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B‐cell chronic lymphocytic leukaemia[J].British Journal of Haematology.2003(2) 被引量:1
  • 7Nelson Beverly P,Gupta Rohit,Dewald Gordon W,Paternoster Sarah F,Rosen Steven T,Peterson LoAnn C.Chronic lymphocytic leukemia FISH panel: impact on diagnosis[].American journal of clinical pathology.2007 被引量:1
  • 8Alex,er Kr?ber,Till Seiler,Axel Benner,Lars Bullinger,Elsbeth Brückle,Peter Lichter,Hartmut D?hner,Stephan Stilgenbau.VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia[].Blood.2002 被引量:1
  • 9David G. Oscier,Anne C. Gardiner,Sarah J. Mould,Sharron Glide,Zadie A. Davis,Rachel E. Ibbotson,Martin M. Corcoran,Robert M. Chapman,Peter W. Thomas,J. Adrian Copplestone,Jenny A. Orchard,Terry J. Hambl.Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors[].Blood.2002 被引量:1
  • 10Christine Mayr,Michael R. Speicher,David M. Kofler,Raymund Buhmann,John Strehl,Raymonde Busch,Michael Hallek,Clemens-Martin Wendtn.Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia[].Blood.2006 被引量:1

二级参考文献30

  • 1Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute Working Group 1996 guidelines. Blood 2008; 111: 5446-5456. 被引量:1
  • 2Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910-1916. 被引量:1
  • 3Mayr C, Speicher MR, Kofler DM, Buhmann R, Strehl J, Busch R, et al. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood 2006; 107: 742-751. 被引量:1
  • 4Dewald GW, Brockman SR, Paternoster SF, Bone ND, O'Fallon JR, Allmer C, et al. Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia. Br J Haematol 2003; 121: 287-295. 被引量:1
  • 5Nelson BP, Gupta R, Dewald GW, Paternoster SF, Rosen ST, Peterson LC. Chronic lymphocytic leukemia FISH panel: impact on diagnosis. Am J Clin Pathol 2007; 128: 323-332. 被引量:1
  • 6Glassman AB, Hayes KJ. The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia. Cancer Genet Cytogenet 2005; 158: 88-91. 被引量:1
  • 7Krober A, Seiler T, Benner A, Bullinger L, Bruckle E, Lichter P, et al. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002; 100: 1410-1416. 被引量:1
  • 8Oscier DG, Gardiner AC, Mould S J, Glide S, Davis ZA, Ibbotson RE, et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002; 100: 1177-1184. 被引量:1
  • 9Durak B, Akay OM, Asian V, Ozdemir M, Sahin F, Artan S, et al. Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 2009; 188: 65-69. 被引量:1
  • 10Nowakowski GS, Dewald GW, Hoyer JD, Patemoster SF, Stockero K J, Fink SR, et al. Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia. Br J Haematol 2005; 130: 36-42. 被引量:1

共引文献8

同被引文献7

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部